Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 187

1.

Assessing the Time Dependence of Prognostic Values of Cytology and Human Papillomavirus Testing in Cervical Cancer Screening.

Isidean SD, Wang Y, Mayrand MH, Ratnam S, Coutlée F, Franco EL, Abrahamowicz M; CCCaST Study Group.

Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31970. [Epub ahead of print]

PMID:
30411802
2.

Naturally Occurring Variations Modulate the Activity of the HPV33 Early Promoter and its Affinity for the E2 Transcription Factor.

Alvarez J, Gagnon D, Coutlée F, Archambault J.

Sci Rep. 2018 Oct 9;8(1):15015. doi: 10.1038/s41598-018-33243-y.

3.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

PMID:
30099516
4.

The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.

McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D; CTN 236 HPV in HIV Study Team.

Clin Infect Dis. 2018 Jul 7. doi: 10.1093/cid/ciy575. [Epub ahead of print]

PMID:
29985988
5.

Impact of Acetic Acid on HPV Testing Using Hybrid Capture 2.

Pina A, Sauthier P, Coutlée F, Trottier H, Mayrand MH.

J Low Genit Tract Dis. 2018 Oct;22(4):352-354. doi: 10.1097/LGT.0000000000000409.

PMID:
29957658
6.

Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.

Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):10-19. doi: 10.1097/QAI.0000000000001727.

PMID:
29757775
7.

Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.

Magnan S, Tota JE, El-Zein M, Burchell AN, Schiller JT, Ferenczy A, Tellier PP, Coutlée F, Franco EL; CATCH Study Group.

Clin Microbiol Infect. 2018 Apr 21. pii: S1198-743X(18)30350-1. doi: 10.1016/j.cmi.2018.04.012. [Epub ahead of print]

PMID:
29684633
8.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

9.

Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study.

Trottier H, Mayrand MH, Coutlée F, Monnier P, Laporte L, Niyibizi J, Carceller AM, Fraser WD, Brassard P, Lacroix J, Francoeur D, Bédard MJ, Girard I, Audibert F.

Papillomavirus Res. 2016 Dec;2:145-152. doi: 10.1016/j.pvr.2016.07.001. Epub 2016 Jul 12.

10.

Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.

Goggin P, Sauvageau C, Gilca V, Defay F, Lambert G, Mathieu-C S, Guenoun J, Comète E, Coutlée F.

Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123. doi: 10.1080/21645515.2017.1385688. Epub 2017 Dec 13.

11.

Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.

Farsi NJ, Rousseau MC, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Souliéres D, Coutlée F, Hier M, Madathil S, Franco EL, Nicolau B.

Carcinogenesis. 2017 Dec 7;38(12):1188-1195. doi: 10.1093/carcin/bgx106.

PMID:
29029021
12.

Estimating HPV DNA Deposition Between Sexual Partners Using HPV Concordance, Y Chromosome DNA Detection, and Self-reported Sexual Behaviors.

Malagón T, Burchell AN, El-Zein M, Guénoun J, Tellier PP, Coutlée F, Franco EL; HITCH Study Group.

J Infect Dis. 2017 Dec 5;216(10):1210-1218. doi: 10.1093/infdis/jix477.

13.

The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.

de Pokomandy A, Kaufman E, de Castro C, Mayrand MH, Burchell AN, Klein M, Charest L, Auger M, Rodrigues-Coutlée S, Coutlée F; EVVA Study Group.

J Infect Dis. 2017 Aug 15;216(4):447-456. doi: 10.1093/infdis/jix273.

PMID:
28931234
14.

Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study.

Malagón T, Burchell A, El-Zein M, Guénoun J, Tellier PP, Coutlée F, Franco EL; HITCH study group.

Sex Transm Dis. 2018 Jan;45(1):28-34. doi: 10.1097/OLQ.0000000000000688.

PMID:
28876295
15.

Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.

de Pokomandy A, Rouleau D, Lalonde R, Beauvais C, de Castro C, Coutlée F; Human Immunodeficiency and Papilloma Virus Research Group (HIPVIRG) Study Group.

HIV Med. 2018 Feb;19(2):81-89. doi: 10.1111/hiv.12544. Epub 2017 Aug 23.

PMID:
28833949
16.

Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2017 Aug 14;13(8):e1006866. doi: 10.1371/journal.pgen.1006866. eCollection 2017 Aug. Erratum in: PLoS Genet. 2018 Mar 1;14 (3):e1007257.

17.

Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Oral Oncol. 2017 Jun;69:56-61. doi: 10.1016/j.oraloncology.2017.03.013. Epub 2017 Apr 10.

PMID:
28559021
18.

Assortativity and Mixing by Sexual Behaviors and Sociodemographic Characteristics in Young Adult Heterosexual Dating Partnerships.

Malagón T, Burchell A, El-Zein M, Tellier PP, Coutlée F, Franco EL; HITCH study group.

Sex Transm Dis. 2017 Jun;44(6):329-337. doi: 10.1097/OLQ.0000000000000612.

19.

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.

Prev Med. 2017 May;98:5-14. doi: 10.1016/j.ypmed.2016.11.029. Epub 2017 Feb 6.

PMID:
28279264
20.

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.

Prev Med. 2017 May;98:15-20. doi: 10.1016/j.ypmed.2016.11.030. Epub 2017 Feb 6.

PMID:
28279257

Supplemental Content

Loading ...
Support Center